Citius Pharmaceuticals, Inc.
CTXRNasdaqCIK 1506251HealthcareFiscal year ends Sep 30
Reports and events: 298 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-112478 |
| 2026-08-2116:15 ET | 8-K | 3.01 Delisting notice | 0001213900-26-092604 |
| 2026-08-1416:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090185 |
| 2026-08-1416:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090181 |
| 2026-08-0509:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-085432 |
| 2026-06-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-063531 |
| 2026-05-1516:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-057876 |
| 2026-05-1516:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057842 |
| 2026-05-0816:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-053916 |
| 2026-04-2916:30 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-049338 |
| 2026-04-2417:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-047599 |
| 2026-04-0616:15 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-040474 |
| 2026-03-3116:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037524 |
| 2026-03-1009:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-025459 |
| 2026-03-0409:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-023439 |
| 2026-02-2408:00 ET | DEF 14A | Proxy statementPeriod 2026-04-06 | 0001213900-26-019566 |
| 2026-02-1308:30 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-015895 |
| 2026-02-1308:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001213900-26-015878 |
| 2026-01-2816:30 ET | 10-K/A | Annual report, amendedPeriod 2025-09-30 | 0001213900-26-008861 |
| 2025-12-2316:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-125413 |
| 2025-12-2316:21 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001213900-25-125333 |
| 2025-12-0117:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116760 |
| 2025-10-2317:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-101741 |
| 2025-10-2116:41 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-100847 |
| 2025-08-1216:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075034 |
| 2025-08-1216:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-074997 |
| 2025-07-0817:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-062099 |
| 2025-06-1208:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053607 |
| 2025-06-0917:29 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-052718 |
| 2025-06-0316:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-050822 |
| 2025-05-3017:15 ET | 8-K | 3.01 Delisting notice | 0001213900-25-049550 |
| 2025-05-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043360 |
| 2025-05-1416:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043362 |
| 2025-04-2807:30 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0001213900-25-035755 |
| 2025-04-1816:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-033366 |
| 2025-04-0316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-028622 |
| 2025-04-0216:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-028003 |
| 2025-03-1016:30 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-022237 |
| 2025-02-1416:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-014359 |
| 2025-02-1416:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001213900-25-014321 |
| 2025-02-0609:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010747 |
| 2025-01-2716:13 ET | 10-K/A | Annual report, amendedPeriod 2024-09-30 | 0001213900-25-006997 |
| 2025-01-2716:05 ET | DEF 14A | Proxy statementPeriod 2025-03-10 | 0001213900-25-006984 |
| 2025-01-0816:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-002071 |
| 2025-01-0709:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-001408 |
| 2024-12-2717:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-113158 |
| 2024-12-2717:00 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001213900-24-113149 |
| 2024-12-2016:30 ET | 8-K | 8.01 Other events | 0001213900-24-111212 |
| 2024-11-2716:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-103453 |
| 2024-11-2616:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-102833 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.